Evaluation of Oral Anticoagulant Use in Atrial Fibrillation Patients

Aliska, Gestina and Rustam, Erlina and Usman, Elly and Raditya, Ivan Mahendra (2019) Evaluation of Oral Anticoagulant Use in Atrial Fibrillation Patients. In: ICOMHER 2021, 13-14 November 2018, Padang, West Sumatera, Indonesia.

[thumbnail of PDF]
Text (PDF)
eai.13-11-2018.2283636 (1).pdf - Published Version

Download (154kB) | Preview


Oral anticoagulant (OAC) is used for thromboembolic prevention in atrial fibrillation (AF) patients. This study aim to observe the use of OAC in AF patients in a tertiary Hospital. We enrolled all patients with complete data of medical record. The data of the use of OAC in AF patients is taken from patients that was hospitalized in Cardiology ward during January 2015-August 2016. Patients were given OAC during hospitalization. Sixty three patients with atrial fibrillation were analysed in this study. Incidence of valvular disease was higher than non-valvular atrial fibrillation (65% vs 35% patients). Most of the patients was women (67.4%). Warfarin as oral anticoagulant for thromboembolic prevention was still more popular than dabigatran (61.8% vs 34.2%). Almost of patients had low HAS-BLED score. The intrahospital bleeding occured in 6% of all patients given warfarin. Warfarin is still used as a mainstay therapy in AF patients for thromboembolic prevention. Bleeding rate due to warfarin use for hospitalized patients was rare

Item Type: Conference or Workshop Item (Paper)
Uncontrolled Keywords: anticoagulants bleeding warfarin
Subjects: R Medicine > R Medicine (General)
Depositing User: EAI Editor IV
Date Deposited: 28 Oct 2021 10:53
Last Modified: 28 Oct 2021 10:53
URI: https://eprints.eudl.eu/id/eprint/7788

Actions (login required)

View Item
View Item